Premium
International Consensus Statement on Allergy and Rhinology: Rhinosinusitis Executive Summary
Author(s) -
Orlandi Richard R.,
Kingdom Todd T.,
Hwang Peter H.
Publication year - 2016
Publication title -
international forum of allergy and rhinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.503
H-Index - 46
eISSN - 2042-6984
pISSN - 2042-6976
DOI - 10.1002/alr.21694
Subject(s) - rhinology , medicine , chronic rhinosinusitis , executive summary , nasal polyps , sinusitis , allergy , evidence based medicine , medline , statement (logic) , dermatology , family medicine , intensive care medicine , otorhinolaryngology , pathology , alternative medicine , surgery , immunology , microbiology and biotechnology , political science , law , biology
Background The body of knowledge regarding rhinosinusitis (RS) continues to expand, with rapid growth in number of publications yet substantial variability in the quality of those presentations. In an effort to both consolidate and critically appraise this information, rhinologic experts from around the world have produced the International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR:RS). This executive summary consolidates the findings of the ICAR:RS document. Methods ICAR:RS presents over 140 topics in the forms of evidence‐based reviews with recommendations (EBRRs) and evidence‐based reviews (EBR). The structured recommendations of the EBRR sections are summarized in this executive summary. Results This summary compiles the EBRRs regarding medical and surgical management of acute RS (ARS) and chronic RS with and without nasal polyps (CRSwNP and CRSsNP). Conclusion This ICAR:RS Executive Summary provides a compilation of the evidence‐based recommendations for medical and surgical treatment of the most common forms of RS.